--- title: "Charles River Laboratorie (CRL.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CRL.US/norm.md" symbol: "CRL.US" name: "Charles River Laboratorie" parent: "https://longbridge.com/en/quote/CRL.US.md" datetime: "2026-05-20T16:18:28.939Z" locales: - [en](https://longbridge.com/en/quote/CRL.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CRL.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CRL.US/norm.md) --- # Charles River Laboratorie (CRL.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.3032 | -5.62 | 1.10 | 1.06 | 0.5000 | | ROE | -1.94% | -33.67% | 6.44% | 6.39% | 3.06% | | Revenue | 995.83M | 994.23M | 1.00B | 1.03B | 984.17M | | Net income | -14.84M | -276.56M | 54.42M | 52.33M | 25.47M | | Operating income | 158.58M | 44.83M | 151.08M | 172.03M | 134.01M | | Gross margin | 32.44% | 33.08% | 35.04% | 37.16% | 34.56% | | Net margin | -1.49% | -27.82% | 5.42% | 5.07% | 2.59% | | Profit quality | 386.05% | 30.39% | 70.66% | 84.08% | 78.05% | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 7.73B | 7.14B | 7.51B | 7.56B | 7.58B | | Leverage | 2.59 | 2.22 | 2.18 | 2.22 | 2.34 | | BVPS | 61.05 | 64.30 | 69.20 | 68.14 | 65.04 | | Turnover | 0.5260 | 0.5477 | 0.5186 | 0.5195 | 0.5113 | | Cash & STI | 191.83M | 213.77M | 207.10M | 182.82M | 229.36M | | Inv & Rec | 359.72M | 299.10M | 302.55M | 279.55M | 290.16M | | LT assets | 1.83B | 2.02B | 1.97B | 1.99B | 1.99B | | Net debt | 2.87B | 2.42B | 2.42B | 2.61B | 2.76B | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | 41.08M | 147.52M | 213.83M | 204.60M | 171.70M | | Investing CF | -407.85M | -92.81M | -33.70M | -37.34M | -45.48M | | Financing CF | 347.72M | -51.86M | -152.62M | -226.92M | -105.33M | | Free CF | 95.20M | 113.21M | 76.79M | 247.11M | 158.27M | | OCF coverage | 9.98% | 49.71% | 73.89% | 26.45% | 82.26% | | Repaid & issued | 912.46M | 156.67M | 107.50M | 547.02M | 416.34M | | CapEx | -55.91M | -88.95M | -35.58M | -35.30M | -59.32M |